Publications by authors named "Erin R Macrae"

12Publications

Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.

Dev Cell 2017 05;41(4):392-407.e6

Solid Tumor Biology Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Department of Molecular Genetics, The Ohio State University, 484 West 12th Avenue, Columbus, OH 43210, USA; Department of Cancer Biology and Genetics, McGill University, Montreal, QC H3A 1A1, Canada; Hollings Cancer Center, Medical University of South Carolina, Hollings Cancer Center 124J, 86 Jonathan Lucas Street, Charleston, SC 29425, USA. Electronic address:

View Article and Find Full Text PDF
May 2017

Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo.

Genes Dev 2015 Aug;29(16):1707-20

Solid Tumor Biology Program, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Genetics, College of Arts and Sciences, The Ohio State University, Columbus, Ohio 43210, USA; Department of Molecular Virology, Immunology, and Medical Genetics, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA;

View Article and Find Full Text PDF
August 2015

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer.

Breast Cancer (Dove Med Press) 2014 23;6:103-13. Epub 2014 Jul 23.

Division of Medical Oncology, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

View Article and Find Full Text PDF
August 2014

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Invest New Drugs 2014 Dec 5;32(6):1285-94. Epub 2014 Jun 5.

Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University's Wexner Medical Center, Starling-Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.

View Article and Find Full Text PDF
December 2014

Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival.

Breast Cancer (Auckl) 2014 12;8:81-8. Epub 2014 May 12.

The Ohio State University Comprehensive Cancer Center, B407 Starling Loving Hall, Columbus, OH, USA.

View Article and Find Full Text PDF
June 2014

Treatment-related mortality with everolimus in cancer patients.

Oncologist 2014 Jun 2;19(6):661-8. Epub 2014 May 2.

The James Cancer Hospital and Richard Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA

View Article and Find Full Text PDF
June 2014